This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kobayashi, N.
Right arrow Articles by Yamaguchi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobayashi, N.
Right arrow Articles by Yamaguchi, A.

 Previous Article  |  Next Article 

Journal of Bacteriology, October 2001, p. 5639-5644, Vol. 183, No. 19
0021-9193/01/$04.00+0   DOI: 10.1128/JB.183.19.5639-5644.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Novel Macrolide-Specific ABC-Type Efflux Transporter in Escherichia coli

Nobuyoshi Kobayashi,1,2 Kunihiko Nishino,1,2,3 and Akihito Yamaguchi1,2,3,*

Faculty of Pharmaceutical Science, Osaka University, Suita, Osaka 565-0871,2 and Department of Cell Membrane Biology, Institute of Scientific and Industrial Research, Osaka University, Ibaraki,1 and CREST, Japan Science and Technology Corporation,3 Osaka 567-0047, Japan

Received 12 March 2001/Accepted 10 July 2001


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In the Escherichia coli genome, five putative open reading frame (ORF) clusters, mdlAB, ybjYZ, yddA, yojHI, and yhiH, have been assumed to be possible genes for ABC drug efflux transporters (I. T. Paulsen, M. K. Sliwinski, and M. H. Saier, Jr., J. Mol. Biol. 277:573-592, 1998). We cloned all of these ORFs in multicopy plasmids and investigated the drug resistance of drug-supersensitive host cells lacking constitutive multidrug efflux transporter genes acrAB. Among them, only ybjYZ gave significant erythromycin resistance and significantly decreased the accumulation of [14C]erythromycin. Therefore, ybjYZ was renamed macAB (macrolide-specific ABC-type efflux carrier). Plasmids carrying both the macA and -B genes conferred resistance against macrolides composed of 14- and 15-membered lactones but no or weak resistance against 16-membered ones. Neither of the two genes produced resistance alone. The DNA sequence suggests that MacB is an integral membrane protein with four transmembrane segments and one nucleotide-binding domain, while MacA belongs to a membrane fusion protein (MFP) family with a signal-like sequence at its N terminus. The expression of the histidine-tagged proteins confirmed that MacB is an integral membrane protein and MacA is a peripheral membrane protein. In addition, MacAB required TolC for its function in a way similar to that of most of the MFP-dependent transporters in E. coli. MacB is thus a novel ABC-type macrolide efflux transporter which functions by cooperating with the MFP MacA and the multifunctional outer membrane channel TolC. This is the first case of an experimentally identified ABC antibiotic efflux transporter in gram-negative organisms.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

ATP-binding cassette (ABC) transporters are the major drug efflux transporters in mammalian cells that cause multidrug resistance of cancer cells (5). On the other hand, ABC transporters are involved mainly in the uptake of a wide range of molecules (13), protein export (13), and the efflux of toxic metal ions, such as an arsenite (23), in bacteria. LmrA in a gram-positive bacterium, Lactococcus lactis (30), has been the only example of an experimentally identified bacterial ABC multidrug exporter. A small number of ABC single-drug exporters for macrolides (22) and daunomycin (21) are also known in gram-positive bacteria, whereas no functional ABC drug exporter has been definitely established to exist in gram-negative bacteria yet (32). The efflux-based multidrug resistance of gram-negative bacteria is most often conferred by RND (resistance-nodulation-cell division) family transporters (9, 15), in addition to some SMR (small multidrug resistance) transporters (18). Efflux-based single-drug resistance of gram-negative bacteria is usually due to plasmid-encoded MFS (major facilitator superfamily) transporters such as tetracycline-H+ antiporters (11, 31).

Complete genomic DNA sequences have been determined for various microorganisms, including Escherichia coli (2). On the basis of these genomic DNA sequences, all of the possible open reading frames (ORFs) can be determined (25), and possible drug exporter genes have been determined (19). As a result, it was found that the E. coli chromosome contains five ORF clusters for possible ABC drug efflux genes (19), i.e., mdlAB, ybjYZ, yddA, yojHI, and yhiH. Recently, we cloned all of these putative ABC transporter genes in multicopy plasmids (14a), and their drug resistance was investigated in drug-supersensitive strain E. coli KAM3 (12), which lacks constitutive multidrug efflux transporter genes acrAB (13). We found that only the ybjYZ gene products confer macrolide-specific drug resistance, and the genes were renamed macAB. In this study, we investigated the macAB gene products and revealed that they comprise a macrolide efflux transporter system. This is the first case of an ABC drug efflux transporter being experimentally established in a gram-negative bacterium.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Materials and bacterial strains. [14C]erythromycin (1.85 GBq/mmol) was purchased from NEN Life Science Products, Inc. Erythromycin, clarithromycin, rokitamycin, azithromycin, oleandomycin, josamycin, and leucomycin were kindly provided by Takeshi Nishino (Kyoto Pharmaceutical University, Kyoto, Japan). All other materials were of reagent grade and were obtained from commercial sources. E. coli AcrAB-deficient strain KAM3 (12) and TolC-deficient strain ZK796 (33) were kindly provided by Tomofusa Tsuchiya and Yuji Morita (Okayama University, Okayama, Japan) and by Hiroshi Nikaido (University of California, Berkeley), respectively. All of the bacterial strains and plasmids used in this study are listed in Table 1.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Bacterial strains and plasmids used in this study

Cloning and expression of ORFs encoding putative ABC transporters. Chromosomal DNA was isolated from E. coli W3104 cells as previously described (14). The DNA fragments including putative ABC transporter ORFs and their upstream regions containing the natural promoters were amplified by the PCR method using primers containing the restriction enzyme site that exists in the multicloning sites of pUC119. The digested DNA fragments containing ORFs were ligated into the multicloning sites of pUC119 in the same direction as the lac promoter (Table 1), and then E. coli KAM3 cells were transformed with these recombinant DNAs.

pUCmacAB carries the 502-bp upstream region containing the native promoter, in addition to the entire macA and macB ORFs. The macA and macB ORFs were individually subcloned into pUC119 as follows. pUCmacA was constructed by subcloning the SmaI fragment of pUCmacAB, in which about one-half of the macB ORF was removed while the 500-bp upstream region and the entire macA ORF were left. For pUCmacB, the macA ORF was removed from pUCmacAB by means of crossover PCR; as a result, the 502-bp upstream region was directly connected to the macB ORF. In order to investigate the intracellular localization of MacA and MacB, the macA and macB genes were also individually subcloned into plasmid pQE70 (Table 1). Plasmid pQE70 carries an optimized promoter-operator element consisting of the phage T5 promoter, which is recognized by E. coli RNA polymerase, and two lac operator sequences. In addition, a six-His tag coding sequence was attached at the 3' terminus of the cloned gene.

Drug resistance determination. The drug resistance of cells was determined by means of a sequential twofold dilution method on yeast extract-Bacto Tryptone agar plates as previously described (14) without induction, and the results were expressed as MICs. E. coli KAM3 cells carry the lacIq gene; thus, the cloned genes are not expressed from the lac promoter without induction. Expression of the putative ABC transporter genes was expected from the native promoters.

Assay of [14C]erythromycin accumulation in E. coli cells. E. coli KAM3/pUCmacAB and its host cells were grown in 30 ml of Luria-Bertani broth at 37°C until they reached an optical density at 600 nm of 0.6. The cells were then harvested and washed twice with 50 mM potassium phosphate buffer (pH 7.0). The cells were then finally suspended in 7.2 ml of the same phosphate buffer. The cell suspension (500 µl) was preincubated with 25 mM glucose at 37°C for 1 min. Erythromycin uptake was started by addition of 5 µl of [14C]erythromycin (1.53-µg/ml solution). At the indicated times, aliquots (250 µl) were withdrawn and filtered through Millipore filters (pore size, 0.45 µm). The filters were washed twice with 700 µl of potassium phosphate buffer, and then the radioactivity was measured with a liquid scintillation counter.


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Drug resistance phenotypes produced by ORFs encoding putative ABC drug efflux transporters. Five putative ABC transporter genes, mdlAB, macAB, yddA, yojHI, and yhiH, were cloned into pUC119 under the control of the native promoters as described in Materials and Methods. Drug-supersensitive strain E. coli KAM3 (12), which lacks constitutive multidrug efflux transporter AcrAB, was transformed with these plasmids. The resistance phenotypes of the cells carrying these plasmids against 22 different drugs and toxic compounds were determined without induction. The MICs (in parentheses in micrograms per milliliter) of the following 21 compounds were unaltered in KAM3 containing mdlAB, macAB, yddA, yojHI, and yhiH: chloramphenicol (0.39), tetracycline (0.39), minocycline (0.20), nalidixic acid (0.78), norfloxacin (0.025), enoxacin (0.05), vancomycin (200), fosfomycin (1.56), doxorubicin (3.13), novobiocin (1.56), rifampin (6.25), trimethoprim (3.13), acriflavine (12.5), crystal violet (1.56), ethidium bromide (12.5), methylviologen (100), tetraphenylphosphonium bromide; (6.25), carbonyl cyanide m-chlorophenylhydrazone (6.25), benzalkonium (3.13), sodium dodecyl sulfate (50), and deoxycholate (1,250). For cells carrying the macAB genes, the MIC of erythromycin was 25 µg/ml, which was eight times higher than the MIC for the host cells (3.13 µg/ml). Plasmids carrying the other four ORF clusters produced no alteration in the MIC of erythromycin.

Amino acid sequences of MacA and MacB. The DNA sequences of the macAB genes were determined by means of the dideoxy sequencing method with an ABI PRISM310 Genetic Analyzer. The ORFs of macA and macB partially overlap; i.e., the sequence ATGA at the end of macA contains the stop codon TGA for macA and the initiation codon ATG for macB (Fig. 1A). There is only one promoter sequence in the upstream region of macA, indicating that macA and macB form one operon. The DNA sequences of the macAB region cloned in this study are the same as those in the reported genome sequence of E. coli (2). MacA has a signal-like sequence composed of 40 amino acid residues at its N terminus, which is rich in positively charged residues in the N-terminal half and hydrophobic residues in the C-terminal half. There is no hydrophobic cluster in the MacA sequence except in this region (Fig. 1B). On the other hand, MacB contains four putative transmembrane (TM) regions in its C-terminal half (Fig. 1C). The N-terminal half of MacB includes a nucleotide-binding cassette domain containing Walker A and B and signature motifs.


View larger version (17K):
[in this window]
[in a new window]
 
FIG. 1.   (A) ORFs of macA and macB, which partially overlap. (B) Hydropathy analysis and prediction of the TM region of MacA. (C) Hydropathy analysis and prediction of the TM region of MacB. NBD, nucleotide-binding domain.

Contributions of MacA, MacB, and the multifunctional outer membrane channel TolC to resistance against macrolide antibiotics. In order to examine the contributions of MacA and MacB to drug resistance, the macA and macB genes were separately subcloned in the pUC119 vector under the control of the natural promoter. The resistance of cells carrying pUCmacAB, pUCmacA, and pUCmacB against various macrolide antibiotics is shown in Table 2. Compared with the MIC for the host KAM3 cells, neither cells carrying pUCmacA nor those carrying pUCmacB showed an increase in resistance.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   Resistance of E. coli KAM3 (Delta acrAB) and ZK796 (Delta tolC) cells harboring a plasmid carrying both the macA and -B genes or one of these genes against macrolide derivatives

On the other hand, cells carrying pUCmacAB exhibited increased resistance against the macrolide antibiotics with 14- and 15-membered rings that were examined. The MICs of erythromycin, clarithromycin, azithromycin, and oleandomycin were eight times as high as those for the host cells. On the other hand, the MICs of 16-membered lactones were increased only twofold (rokitamycin and josamycin) or not changed (leucomycin).

In order to investigate the role of the multifunctional outer membrane channel TolC in the MacAB system, TolC-deficient E. coli ZK796 was transformed with pUCmacAB. The resulting transformed cells showed no increase in resistance (Table 2), indicating that the MacAB system depends on TolC.

Intracellular localization of MacA and MacB. In order to reveal the intracellular localization of MacA and MacB, the macA and macB genes were separately subcloned into vector pQE70 to attach polyhistidine tags at their C termini. The expression of MacA and MacB was induced with isopropyl-beta -D-thiogalactopyranoside (IPTG). Cells carrying pUCmacAB, pQEmacA, and pQEmacB were disrupted by brief sonication, and then supernatants (S) and membrane fractions (P) were obtained by ultracentrifugation. After sodium dodecyl sulfate-polyacrylamide gel electrophoresis, total proteins were visualized by Coomassie brilliant blue (CBB) staining and MacA and MacB were visualized by Western blotting with anti-polyhistidine serum (Fig. 2A). Both MacA (40 kDa) and MacB (70 kDa) bands were observed only for the membrane fractions (Fig. 2A, lanes 4 and 5). Both bands were also detected for the membrane fraction of cells carrying pUCmacAB on CBB staining (Fig. 2A, lane 3).


View larger version (50K):
[in this window]
[in a new window]
 
FIG. 2.   Expression and localization of MacA and MacB. (A) Expression of MacA and MacB under the control of the native promoter (pUC plasmids) and the T5 promoter (pQE plasmids) with a polyhistidine tag at the N-terminal end. In the case of pQE plasmids, expression was induced with IPTG. Cells were disrupted by brief sonication, and supernatant (S) and precipitated (membrane) (P) fractions were obtained by ultracentrifugation after removal of cell debris by brief low-speed centrifugation. Lanes 1, 2, and 3 were stained with CBB, and lanes 4 and 5 were visualized by Western blotting. Lanes: 1, cells carrying pQEmacA; 2, pQEmacB; 3, pUCmacAB; 4, pQEmacA; 5, pQEmacB. (B) Fractionation of MacA with 4.5 M urea washing or potassium phosphate buffer washing as a control. Lanes 1, 2, and 3 were stained with CBB, and lanes 4, 5, and 6 were visualized by Western blotting. S and P indicate the supernatants and precipitates obtained on ultracentrifugation, respectively. Lanes: 1 and 3, briefly sonicated cells carrying pQEmacA; 2 and 5, after 4.5 M urea washing of the precipitate (lane 1, P); 3 and 6, after potassium phosphate buffer washing of the precipitate (lane 1, P).

The membrane fraction of cells expressing MacA was treated with 4.5 M urea, and a supernatant and a precipitate were obtained by ultracentrifugation. A significant amount of MacA was released from the membrane fraction and detected in the supernatant fraction by Western blotting (Fig. 2B, lane 5). In contrast, when the membrane was treated with potassium phosphate buffer, MacA was not released from it (Fig. 2B, lane 6). These observations suggest that MacA is a peripheral membrane protein.

Uptake of [14C]erythromycin by cells carrying pUCmacAB. In order to determine whether or not macrolide resistance is based on the active efflux of drugs, we compared the uptake of [14C]erythromycin by E. coli KAM3 cells with and without the pUCmacAB plasmid (Fig. 3). [14C]erythromycin was taken up by the host KAM3 cells. In cells carrying pUCmacAB, uptake was significantly inhibited, indicating active efflux of this drug out of the cells.


View larger version (21K):
[in this window]
[in a new window]
 
FIG. 3.   Accumulation of [14C]erythromycin in cells carrying pUCmacAB and pUC119. Cells were incubated with 25 mM glucose and 1.53 µg of [14C]erythromycin per ml as described in Materials and Methods. Aliquots were then filtered through Millipore filters. After washing of the filters, radioactivity was measured with a liquid scintillation counter. Radioactivity is indicated as disintegrations per minute. Open symbols, cells carrying pUCmacAB; closed symbols, cells carrying pUC119.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In this study, we showed that the MacAB complex confers TolC-dependent macrolide resistance via active drug efflux. We examined the resistance pattern against 22 different drugs and toxic compounds which contain the typical compounds exported by multidrug transporters in bacteria and mammals. As a result, MacAB was revealed to confer macrolide-specific resistance. As shown in Fig. 4, MacB is a half-type ABC protein having four putative TM segments and one nucleotide-binding cassette. There is a large hydrophilic loop region between TM1 and TM2, which is probably located on the periplasmic surface and may interact with MacA. MacA is a peripheral membrane protein that belongs to the membrane fusion protein (MFP) family (4). According to the sequence characteristics of the signal-like sequence and the positive-inside rule of protein topogenesis (20), most of the MacA molecule seems to be secreted and attached on the periplasmic surface (Fig. 4).


View larger version (38K):
[in this window]
[in a new window]
 
FIG. 4.   Schematic model of the molecular construction of the novel ABC-type macrolide-specific drug exporter MacA-MacB system complexed with TolC in E. coli. The dotted line indicates the region having a signal-like sequence. NBD indicates a possible nucleotide-binding domain having Walker A and B and signature motifs.

A BLAST search revealed that there are homologues of macAB in gram-negative organisms. Putative ABC transporter proteins NMA0729 (16) and NMB0548 (29) in Neisseria meningitidis, PA2389 in Pseudomonas aeruginosa (26), and CAB75243.1 in Campylobacter jejuni (17) exhibit sequence identity with MacB, i.e., 48, 48, 43, and 41%, respectively. They show sequence similarity not only in the ATP-binding domains but also in the TM domains. In contrast, the sequence similarity between MacB and putative ABC transporters such as MsrA (24) in gram-positive organisms is restricted to the ATP-binding cassette region. The putative ABC transporter genes in the gram-negative organisms mentioned above include genes for MacA homologues in the same operon. Therefore, these genes can be classified into the same subfamily of ABC transporters in gram-negative organisms.

In eukaryotes, most ABC transporters are involved in multidrug resistance. However, in bacteria, the majority of drug exporters are drug-proton antiporters (8), including MFS-, SMR-, and RND-type transporters, while ABC transporters are usually involved in the uptake of a wide range of molecules (6). On the basis of the results of genome analysis, a number of putative ABC drug exporters are predicted (19), while the only ABC multidrug exporter experimentally identified in a bacterium is LmrA in Lactococcus lactis (30). In gram-positive organisms, some macrolide resistance genes code for ABC-type efflux transporter proteins (22, 24). Among them, MsrAB in Staphylococcus species has two nucleotide-binding domains and probably acts as an efflux system in cooperating with some other integral membrane proteins (10), while its characteristics as a drug exporter have not been fully revealed. As for macrolide exporters, some major facilitator-type exporters are known in gram-positive organisms (3, 28), such as MefA, which, similarly to MacAB, confers resistance against macrolides with 14- and 15-membered lactones.

A half-type ABC transporter is usually expected to have six TM segments (1, 30). MacB appears to have four TM segments. In addition, the N-terminal ABC on an ABC transporter is also unusual. Among the ABC transporters hitherto reported, only the ABCG subfamily in mammalian cells shows an N-terminal ABC (7). MacB requires the MFP MacA and the outer membrane channel TolC for drug efflux function. Although some bacterial ABC transporters such as HlyB (34) accompany an MFP and TolC, it is quite interesting that ABC-type drug efflux transporters depend on an MFP and TolC, as seen with RND-type multidrug efflux transporters (9, 13). In short, MacAB represents a quite unique and novel bacterial subfamily of ABC transporters.

Very recently, Sulavik et al. (27) constructed 22 E. coli strains with deletions of putative drug efflux transporters and outer membrane channels. The strain with a deletion of the macAB (ybjYZ) genes showed no change in drug susceptibility. However, since the macAB deletion strain carried the acrAB genes, the effect of macAB deletion might have been masked. The tolerance of E. coli cells to macrolide antibiotics is conferred mainly by AcrAB (35). Expression cloning of an individual gene into an AcrAB-deficient strain may be necessary to discover a potential drug efflux transporter gene.


    ACKNOWLEDGMENTS

This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. K. Nishino is supported by a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists.

K. Nishino and N. Kobayashi contributed equally to this work, and both should be considered first authors.


    FOOTNOTES

* Corresponding author. Mailing address: Institute of Scientific and Industrial Research, Osaka University, 8-1 Mihogaoka, Ibaraki-shi, Osaka 567-0047, Japan. Phone: 81-6-6879-8545. Fax: 81-6-6879-8549. E-mail: akihito{at}sanken.osaka-u.ac.jp.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Abele, R., and R. Tampe. 1999. Function of the transport complex TAP in cellular immune recognition. Biochim. Biophys. Acta 1461:405-419[Medline].
2. Blattner, F. R., G. Plunkett, C. A. Bloch, N. T. Perna, V. Burland, M. Riley, J. Collado-Vides, J. D. Glasner, C. K. Rode, G. F. Mayhew, J. Gregor, N. W. Davis, H. A. Kirkpatrick, M. A. Goeden, D. J. Rose, B. Mau, and Y. Shao. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1474[Abstract/Free Full Text].
3. Clancy, J., J. Petitpas, F. Dib-Hajj, W. Yuan, M. Cronan, A. V. Kamath, J. Bergeron, and J. A. Retsema. 1996. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol. 22:867-879[CrossRef][Medline].
4. Dinh, T., I. T. Paulsen, and M. H. Saier. 1994. A family of extracytoplasmic proteins that allow transport of large molecules across the outer membranes of gram-negative bacteria. J. Bacteriol. 176:3825-3831[Abstract/Free Full Text].
5. Gottesman, M. M., and I. Pastan. 1993. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:385-427[CrossRef][Medline].
6. Holland, I. B., and M. A. Blight. 1999. ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. J. Mol. Biol. 293:381-399[CrossRef][Medline].
7. Klein, I., B. Sarkadi, and A. Varadi. 1999. An inventory of the human ABC proteins. Biochim. Biophys. Acta 1461:237-262[Medline].
8. Levy, S. B. 1992. Active efflux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother. 36:695-703[Free Full Text].
9. Li, X.-Z., H. Nikaido, and K. Poole. 1995. Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:1948-1953[Abstract].
10. Matsuoka, M., K. Endou, H. Kobayashi, M. Inoue, and Y. Nakajima. 1998. A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus. FEMS Microbiol. Lett. 167:221-227[CrossRef][Medline].
11. McMurry, L., R. E. Petrucci, Jr., and S. B. Levy. 1980. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc. Natl. Acad. Sci. USA 77:3974-3977[Abstract/Free Full Text].
12. Morita, Y., K. Kodama, S. Shiota, T. Mine, A. Kataoka, T. Mizushima, and T. Tsuchiya. 1998. NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob. Agents Chemother. 42:1778-1782[Abstract/Free Full Text].
13. Nikaido, H., and J. A. Hall. 1998. Overview of bacterial ABC transporters. Methods Enzymol. 292:3-20[Medline].
14. Nishino, K., and A. Yamaguchi. 2001. Overexpression of the response regulator evgA of the two-component signal transduction system modulates multidrug resistance conferred by multidrug resistance transporters. J. Bacteriol. 183:1455-1458[Abstract/Free Full Text].
14a. Nishino, K., and A. Yamaguchi. Analysis of a complete library of putative drug transporter genes in Escherichia coli. J. Bacteriol., in press.
15. Okusu, H., D. Ma, and H. Nikaido. 1996. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J. Bacteriol. 178:306-308[Abstract/Free Full Text].
16. Parkhill, J., M. Achtman, K. D. James, S. D. Bentley, C. Churcher, S. R. Klee, G. Morelli, D. Basham, D. Brown, T. Chillingworth, R. M. Davies, P. Davis, K. Devlin, T. Feltwell, N. Hamlin, S. Holroyd, K. Jagels, S. Leather, S. Moule, K. Mungall, M. A. Quail, M. A. Rajandream, K. M. Rutherford, M. Simmonds, J. Skelton, S. Whitehead, B. G. Spratt, and B. G. Barrell. 2000. Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature 404:502-506[CrossRef][Medline].
17. Parkhill, J., B. W. Wren, K. Mungall, J. M. Ketley, C. Churcher, D. Basham, T. Chillingworth, R. M. Davies, T. Feltwell, S. Holroyd, K. Jagels, A. V. Karlyshev, S. Moule, M. J. Pallen, C. W. Penn, M. A. Quail, M.-A. Rajandream, K. M. Rutherford, A. H. van Vliet, S. Whitehead, and B. G. Barrell. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403:665-668[CrossRef][Medline].
18. Paulsen, I. T., R. A. Skurray, R. Tam, M. H. Saier, Jr., R. J. Turner, J. H. Weiner, E. B. Goldberg, and L. L. Grinius. 1996. The SMR family: a novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs. Mol. Microbiol. 19:1167-1175[Medline].
19. Paulsen, I. T., M. K. Sliwinski, and M. H. Saier, Jr. 1998. Microbial genome analyses: global comparisons of transport capabilities based on phylogenies, bioenergetics and substrate specificities. J. Mol. Biol. 277:573-592[CrossRef][Medline].
20. Persson, B., and P. Argos. 1996. Topology prediction of membrane proteins. Protein Sci. 5:363-371[Medline].
21. Reizer, J., A. Reizer, and M. H. Saier, Jr. 1992. A new subfamily of bacterial ABC-type transport systems catalyzing export of drugs and carbohydrates. Protein Sci. 1:1326-1332[Medline].
22. Roberts, M. C., J. Sutcliffe, P. Courvalin, L. B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830[Free Full Text].
23. Rosen, B. P. 1999. Families of arsenic transporters. Trends Microbiol. 7:207-212[CrossRef][Medline].
24. Ross, J. I., E. A. Eady, J. H. Cove, W. J. Cunliffe, S. Baumberg, and J. C. Wootton. 1990. Inducible erythromycin resistance in Staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol. Microbiol. 4:1207-1214[CrossRef][Medline].
25. Rudd, K. E. 1998. Linkage map of Escherichia coli K-12, edition 10: the physical map. Microbiol. Mol. Biol. Rev. 62:985-1019[Abstract/Free Full Text].
26. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, R. L. Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, L. L. Brody, S. N. Coulter, K. R. Folger, A. Kas, K. Larbig, R. Lim, K. Smith, D. Spencer, G. K. Wong, Z. Wu, I. T. Paulsen, J. Reizer, M. H. Saier, R. E. W. Hancock, S. Lory, and M. V. Olson. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959-964[CrossRef][Medline].
27. Sulavik, M. C., C. Houseweart, C. Cramer, N. Jiwani, N. Murgolo, J. Greene, B. Didomenico, K. J. Shaw, G. H. Miller, R. Hare, and G. Shimer. 2001. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob. Agents Chemother. 45:1126-1136[Abstract/Free Full Text].
28. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824[Abstract].
29. Tettelin, H., N. J. Saunders, J. Heidelberg, A. C. Jeffries, K. E. Nelson, J. A. Eisen, K. A. Ketchum, D. W. Hood, J. F. Peden, R. J. Dodson, W. C. Nelson, M. L. Gwinn, R. DeBoy, J. D. Peterson, E. K. Hickey, D. H. Haft, S. L. Salzberg, O. White, R. D. Fleischmann, B. A. Dougherty, T. Mason, A. Ciecko, D. S. Parksey, E. Blair, H. Cittone, E. B. Clark, M. D. Cotton, T. R. Utterback, H. Khouri, H. Qin, J. Vamathevan, J. Gill, V. Scarlato, V. Masignani, M. Pizza, G. Grandi, L. Sun, H. O. Smith, C. M. Fraser, E. R. Moxon, R. Rappuoli, and J. C. Venter. 2000. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287:1809-1815[Abstract/Free Full Text].
30. van Veen, H. W., K. Venema, H. Bolhuis, I. Oussenko, J. Kok, B. Poolman, A. J. Driessen, and W. N. Konings. 1996. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc. Natl. Acad. Sci. USA 93:10668-10672[Abstract/Free Full Text].
31. Yamaguchi, A., T. Udagawa, and T. Sawai. 1990. Transport of divalent cations with tetracycline as mediated by the transposon Tn10-encoded tetracycline resistance protein. J. Biol. Chem. 265:4809-4813[Abstract/Free Full Text].
32. Young, J., and I. B. Holland. 1999. ABC transporters: bacterial exporters-revisited five years on. Biochim. Biophys. Acta 1461:177-200[Medline].
33. Zgurskaya, H. I., and H. Nikaido. 2000. Cross-linked complex between oligomeric periplasmic lipoprotein AcrA and the inner-membrane-associated multidrug efflux pump AcrB from Escherichia coli. J. Bacteriol. 182:4264-4267[Abstract/Free Full Text].
34. Zhang, F., J. A. Sheps, and V. Ling. 1993. Complementation of transport-deficient mutants of Escherichia coli alpha-hemolysin by second-site mutations in the transporter hemolysin B. J. Biol. Chem. 268:19889-19895[Abstract/Free Full Text].
35. Zhong, P., and V. D. Shortridge. 2000. The role of efflux in macrolide resistance. Drug Resist. Updates 3:325-329[CrossRef][Medline].


Journal of Bacteriology, October 2001, p. 5639-5644, Vol. 183, No. 19
0021-9193/01/$04.00+0   DOI: 10.1128/JB.183.19.5639-5644.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Blair, J. M. A., La Ragione, R. M., Woodward, M. J., Piddock, L. J. V. (2009). Periplasmic adaptor protein AcrA has a distinct role in the antibiotic resistance and virulence of Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 64: 965-972 [Abstract] [Full Text]  
  • Tikhonova, E. B., Dastidar, V., Rybenkov, V. V., Zgurskaya, H. I. (2009). Kinetic control of TolC recruitment by multidrug efflux complexes. Proc. Natl. Acad. Sci. USA 106: 16416-16421 [Abstract] [Full Text]  
  • Arends, S. J. R., Kustusch, R. J., Weiss, D. S. (2009). ATP-Binding Site Lesions in FtsE Impair Cell Division. J. Bacteriol. 191: 3772-3784 [Abstract] [Full Text]  
  • Lin, H. T., Bavro, V. N., Barrera, N. P., Frankish, H. M., Velamakanni, S., van Veen, H. W., Robinson, C. V., Borges-Walmsley, M. I., Walmsley, A. R. (2009). MacB ABC Transporter Is a Dimer Whose ATPase Activity and Macrolide-binding Capacity Are Regulated by the Membrane Fusion Protein MacA. J. Biol. Chem. 284: 1145-1154 [Abstract] [Full Text]  
  • Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeno-Tarraga, A. M., Thomson, N. R., Bason, N., Quail, M. A., Sharp, S., Cherevach, I., Churcher, C., Goodhead, I., Hauser, H., Holroyd, N., Mungall, K., Scott, P., Walker, D., White, B., Rose, H., Iversen, P., Mil-Homens, D., Rocha, E. P. C., Fialho, A. M., Baldwin, A., Dowson, C., Barrell, B. G., Govan, J. R., Vandamme, P., Hart, C. A., Mahenthiralingam, E., Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients. J. Bacteriol. 191: 261-277 [Abstract] [Full Text]  
  • Yamanaka, H., Kobayashi, H., Takahashi, E., Okamoto, K. (2008). MacAB Is Involved in the Secretion of Escherichia coli Heat-Stable Enterotoxin II. J. Bacteriol. 190: 7693-7698 [Abstract] [Full Text]  
  • Moore, S. D., Sauer, R. T. (2008). Revisiting the mechanism of macrolide-antibiotic resistance mediated by ribosomal protein L22. Proc. Natl. Acad. Sci. USA 105: 18261-18266 [Abstract] [Full Text]  
  • Jacquet, E., Girard, J.-M., Ramaen, O., Pamlard, O., Levaique, H., Betton, J.-M., Dassa, E., Chesneau, O. (2008). ATP Hydrolysis and Pristinamycin IIA Inhibition of the Staphylococcus aureus Vga(A), a Dual ABC Protein Involved in Streptogramin A Resistance. J. Biol. Chem. 283: 25332-25339 [Abstract] [Full Text]  
  • Dubern, J.-F., Coppoolse, E. R., Stiekema, W. J., Bloemberg, G. V. (2008). Genetic and functional characterization of the gene cluster directing the biosynthesis of putisolvin I and II in Pseudomonas putida strain PCL1445. Microbiology 154: 2070-2083 [Abstract] [Full Text]  
  • Davidson, A. L., Dassa, E., Orelle, C., Chen, J. (2008). Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems. Microbiol. Mol. Biol. Rev. 72: 317-364 [Abstract] [Full Text]  
  • de Bruijn, I., de Kock, M. J. D., de Waard, P., van Beek, T. A., Raaijmakers, J. M. (2008). Massetolide A Biosynthesis in Pseudomonas fluorescens. J. Bacteriol. 190: 2777-2789 [Abstract] [Full Text]  
  • Matsuo, T., Chen, J., Minato, Y., Ogawa, W., Mizushima, T., Kuroda, T., Tsuchiya, T. (2008). SmdAB, a Heterodimeric ABC-Type Multidrug Efflux Pump, in Serratia marcescens. J. Bacteriol. 190: 648-654 [Abstract] [Full Text]  
  • Kamal, N., Rouquette-Loughlin, C., Shafer, W. M. (2007). The TolC-Like Protein of Neisseria meningitidis Is Required for Extracellular Production of the Repeats-in-Toxin Toxin FrpC but Not for Resistance to Antimicrobials Recognized by the Mtr Efflux Pump System. Infect. Immun. 75: 6008-6012 [Abstract] [Full Text]  
  • Murata, T., Tseng, W., Guina, T., Miller, S. I., Nikaido, H. (2007). PhoPQ-Mediated Regulation Produces a More Robust Permeability Barrier in the Outer Membrane of Salmonella enterica Serovar Typhimurium. J. Bacteriol. 189: 7213-7222 [Abstract] [Full Text]  
  • Lubelski, J., Konings, W. N., Driessen, A. J. M. (2007). Distribution and Physiology of ABC-Type Transporters Contributing to Multidrug Resistance in Bacteria. Microbiol. Mol. Biol. Rev. 71: 463-476 [Abstract] [Full Text]  
  • Perez, A., Canle, D., Latasa, C., Poza, M., Beceiro, A., del Mar Tomas, M., Fernandez, A., Mallo, S., Perez, S., Molina, F., Villanueva, R., Lasa, I., Bou, G. (2007). Cloning, Nucleotide Sequencing, and Analysis of the AcrAB-TolC Efflux Pump of Enterobacter cloacae and Determination of Its Involvement in Antibiotic Resistance in a Clinical Isolate. Antimicrob. Agents Chemother. 51: 3247-3253 [Abstract] [Full Text]  
  • Bogdanovich, T., Bozdogan, B., Appelbaum, P. C. (2006). Effect of Efflux on Telithromycin and Macrolide Susceptibility in Haemophilus influenzae. Antimicrob. Agents Chemother. 50: 893-898 [Abstract] [Full Text]  
  • Wang, N., Lu, S.-E., Yang, Q., Sze, S.-H., Gross, D. C. (2006). Identification of the syr-syp Box in the Promoter Regions of Genes Dedicated to Syringomycin and Syringopeptin Production by Pseudomonas syringae pv. syringae B301D. J. Bacteriol. 188: 160-168 [Abstract] [Full Text]  
  • Rouquette-Loughlin, C. E., Balthazar, J. T., Shafer, W. M. (2005). Characterization of the MacA-MacB efflux system in Neisseria gonorrhoeae. J Antimicrob Chemother 56: 856-860 [Abstract] [Full Text]  
  • Bleuel, C., Grosse, C., Taudte, N., Scherer, J., Wesenberg, D., Krauss, G. J., Nies, D. H., Grass, G. (2005). TolC Is Involved in Enterobactin Efflux across the Outer Membrane of Escherichia coli. J. Bacteriol. 187: 6701-6707 [Abstract] [Full Text]  
  • Poole, K. (2005). Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56: 20-51 [Abstract] [Full Text]  
  • Chesneau, O., Ligeret, H., Hosan-Aghaie, N., Morvan, A., Dassa, E. (2005). Molecular Analysis of Resistance to Streptogramin A Compounds Conferred by the Vga Proteins of Staphylococci. Antimicrob. Agents Chemother. 49: 973-980 [Abstract] [Full Text]  
  • Nishino, K., Honda, T., Yamaguchi, A. (2005). Genome-Wide Analyses of Escherichia coli Gene Expression Responsive to the BaeSR Two-Component Regulatory System. J. Bacteriol. 187: 1763-1772 [Abstract] [Full Text]  
  • Igarashi, Y., Aoki, K. F., Mamitsuka, H., Kuma, K.-i., Kanehisa, M. (2004). The Evolutionary Repertoires of the Eukaryotic-Type ABC Transporters in Terms of the Phylogeny of ATP-binding Domains in Eukaryotes and Prokaryotes. Mol Biol Evol 21: 2149-2160 [Abstract] [Full Text]  
  • Chollet, R., Chevalier, J., Bryskier, A., Pages, J.-M. (2004). The AcrAB-TolC Pump Is Involved in Macrolide Resistance but Not in Telithromycin Efflux in Enterobacter aerogenes and Escherichia coli. Antimicrob. Agents Chemother. 48: 3621-3624 [Abstract] [Full Text]  
  • Chou, H.-C., Lee, C.-Z., Ma, L.-C., Fang, C.-T., Chang, S.-C., Wang, J.-T. (2004). Isolation of a Chromosomal Region of Klebsiella pneumoniae Associated with Allantoin Metabolism and Liver Infection. Infect. Immun. 72: 3783-3792 [Abstract] [Full Text]  
  • Nishino, K., Yamaguchi, A. (2004). Role of Histone-Like Protein H-NS in Multidrug Resistance of Escherichia coli. J. Bacteriol. 186: 1423-1429 [Abstract] [Full Text]  
  • Schmidt, K. L., Peterson, N. D., Kustusch, R. J., Wissel, M. C., Graham, B., Phillips, G. J., Weiss, D. S. (2004). A Predicted ABC Transporter, FtsEX, Is Needed for Cell Division in Escherichia coli. J. Bacteriol. 186: 785-793 [Abstract] [Full Text]  
  • Nishino, K., Yamada, J., Hirakawa, H., Hirata, T., Yamaguchi, A. (2003). Roles of TolC-Dependent Multidrug Transporters of Escherichia coli in Resistance to {beta}-Lactams. Antimicrob. Agents Chemother. 47: 3030-3033 [Abstract] [Full Text]  
  • Huda, N., Lee, E.-W., Chen, J., Morita, Y., Kuroda, T., Mizushima, T., Tsuchiya, T. (2003). Molecular Cloning and Characterization of an ABC Multidrug Efflux Pump, VcaM, in Non-O1 Vibrio cholerae. Antimicrob. Agents Chemother. 47: 2413-2417 [Abstract] [Full Text]  
  • Sheehan, B. J., Bosse, J. T., Beddek, A. J., Rycroft, A. N., Kroll, J. S., Langford, P. R. (2003). Identification of Actinobacillus pleuropneumoniae Genes Important for Survival during Infection in Its Natural Host. Infect. Immun. 71: 3960-3970 [Abstract] [Full Text]  
  • Van Bambeke, F., Glupczynski, Y., Plesiat, P., Pechere, J. C., Tulkens, P. M. (2003). Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J Antimicrob Chemother 51: 1055-1065 [Full Text]  
  • Nishino, K., Inazumi, Y., Yamaguchi, A. (2003). Global Analysis of Genes Regulated by EvgA of the Two-Component Regulatory System in Escherichia coli. J. Bacteriol. 185: 2667-2672 [Abstract] [Full Text]  
  • Hirakawa, H., Nishino, K., Hirata, T., Yamaguchi, A. (2003). Comprehensive Studies of Drug Resistance Mediated by Overexpression of Response Regulators of Two-Component Signal Transduction Systems in Escherichia coli. J. Bacteriol. 185: 1851-1856 [Abstract] [Full Text]  
  • Mc Dermott, P. F., Walker, R. D., White, D. G. (2003). Antimicrobials: Modes of Action and Mechanisms of Resistance. International Journal of Toxicology 22: 135-143 [Abstract]  
  • Masuda, N., Church, G. M. (2002). Escherichia coli Gene Expression Responsive to Levels of the Response Regulator EvgA. J. Bacteriol. 184: 6225-6234 [Abstract] [Full Text]  
  • Nagakubo, S., Nishino, K., Hirata, T., Yamaguchi, A. (2002). The Putative Response Regulator BaeR Stimulates Multidrug Resistance of Escherichia coli via a Novel Multidrug Exporter System, MdtABC. J. Bacteriol. 184: 4161-4167 [Abstract] [Full Text]  
  • Nishino, K., Yamaguchi, A. (2002). EvgA of the Two-Component Signal Transduction System Modulates Production of the YhiUV Multidrug Transporter in Escherichia coli. J. Bacteriol. 184: 2319-2323 [Abstract] [Full Text]  
  • Nishino, K., Yamaguchi, A. (2001). Analysis of a Complete Library of Putative Drug Transporter Genes in Escherichia coli. J. Bacteriol. 183: 5803-5812 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kobayashi, N.
Right arrow Articles by Yamaguchi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobayashi, N.
Right arrow Articles by Yamaguchi, A.